Sun BB, et al. Genomic atlas of the human plasma proteome. Nature. 2018 June 7; 558:73-79.
Lane WJ, et al. Automated typing of red blood cell and platelet antigens: a whole-genome sequencing study. Lancet Haematol. 2018 May.
Didriksen M, et al. Restless legs syndrome is associated with major comorbidities in a population of Danish blood donors. Sleep Med. 2018 May; 45:124-131.
O’Keeffe LM, et al. Medium and long-term health risks in living kidney donors: a systematic review and meta-analysis. Annals of Internal Medicine. 2018 Feb 20; 168(4):276-284.
Di Angelantonio E, et al. Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors. Lancet. 2017 Nov 25; 390(10110):2360-2371.
Schormair B, et al. Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis. Lancet Neurol. 2017 Nov; 16(11):898-907.
Goldman M, et al. Comparison of donor and general population demographics over time: a BEST Collaborative group study. Transfusion. 2017 Oct; 57(10):2469-2476.
Petersen R, et al. Platelet function is modified by common sequence variation in megakaryocyte super enhancers. Nat Commun. 2017 Jul; 8:16058.
Harrison JM, et al. Respiratory and hemodynamic contributions to emotion-related pre-syncopal vasovagal symptoms. Biological Psychology. 2017 April 26; 127:46-52.
Moore C, et al. Recruitment and representativeness of blood donors in the INTERVAL randomised trial assessing varying inter-donation intervals. Trials. 2016;17:458.
Astle WJ, et al. The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. Cell. 2016;167, 1415–1429.
Moore C, et al. The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial. Trials. 2014;15:363.